Palm Beach physician pioneering new advances in ALS and inflammatory disease treatment
Dr. Simrit Parmar, a Northwestern University-trained oncologist and research scientist, launched Cellenkos Inc., in 2016 to accelerate the clinical development of "T regulatory cell" therapies for the treatment of autoimmune diseases and inflammatory disorders.
T regulatory cells, or Tregs (pronounced tee-regs), are natural immune system regulator cells that suppress the activity of other immune cells to prevent excessive inflammation and autoimmune reactions.
Before launching Cellenkos, Parmar conducted extensive research on these cells and developed therapies based on them.
While working as an oncologist/hematologist in the Department of Stem Cell Transplantation and Cellular Therapy at the University of Texas's MD Anderson Cancer in Houston in 2009, she developed treatments using T regulatory cells derived from umbilical cord blood to help prevent graft-versus-host disease (GVHD), a complication that can occur after an allogeneic stem cell or bone marrow transplant.
Parmar told the Daily News it was 'very discouraging' to watch patients die from GVHD, which motivated her to focus her research on controlling the inflammation caused by donor cells, starting with the discovery of T regulatory cells. As she continued to conduct her research, she discovered that these cells had uses beyond preventing GVHD.
"We found that the application of these cells is beyond just that one niche," she told the Daily News. "It can be applied to any autoimmune disease, to any inflammatory disorder."
In 2016, the cell technology Parmar developed at MD Anderson was licensed to Cellenkos, which now supports her ongoing research through a sponsored research agreement.
Since then, Parmar has focused on her work advancing targeted Treg cell therapies designed to ease inflammation and regulate immune function.
Cellenkos is currently in clinical trials for various inflammatory and autoimmune diseases, including ALS, bone marrow failure, severe COVID-19 and myelofibrosis. Results have been positive so far, Parmar said, noting that ALS patients have seen a delay in disease progression and functional decline and an improvement in quality of life.
"We have made some great strides in neurodegenerative disease," she said. "We just published a paper in the New England Journal of Medicine Evidence on ALS, where we showed not only disease halting, but slight improvement in resolving inflammation. That research has applications beyond just ALS. We are hoping as we are garnering more funding, we can go after Parkinson's, Alzheimer's and multiple sclerosis."
Inflammation is the root cause of many diseases including cardiac, respiratory, neurological and hematological disorders, Parmar said, and it also drives many autoimmune diseases.
Parmar's cell therapies restore immune balance by targeting harmful T cells — a type of white blood cell called lymphocytes — that can mistakenly attack healthy cells in the body, and retraining the body's own defense mechanisms.
"We have a drug that heals inside out," she said. "We believe that we neutralize the bad player, which may not have initiated the inflammation, but definitely plays a key role in the propagation of widespread inflammation."
Parmar, a mother of three who lives in Palm Beach's North End and travels regularly to Houston, where Cellenkos is based, said she remains committed to developing cell therapies targeting a broad range of autoimmune and inflammatory diseases.
Cellenkos is pursuing funding for larger ALS research studies in the U.S., and it is also preparing for the next phase of clinical trials required for federal Food and Drug Administration approval.
Parmar said she sees Palm Beach County's emergence as a neuroscience hub as a key benefit of her move, and she hopes it will lead to new research, development, and partnership opportunities.
"We're incredibly excited about the momentum building in the Palm Beach and Jupiter area around neuroscience innovation," she said. "With new opportunities for R&D collaboration in the region, it presents an ideal environment for us to expand. We see great potential not only to develop a manufacturing facility for neurological compounds … but also to establish a dedicated treatment center that brings these breakthroughs directly to patients.'
Jodie Wagner is a journalist at the Palm Beach Daily News, part of the USA TODAY Florida Network. You can reach her at jwagner@pbdailynews.com.
This article originally appeared on Palm Beach Daily News: Palm Beach physician-scientist pioneering groundbreaking ALS therapy
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
44 minutes ago
- CBS News
Impending mayfly hatch causes southeastern Minnesota bridge to go dark
The lights will go out on a bridge over the Mississippi River in Winona, Minnesota, for the next few weeks to squelch the impact of a mayfly hatch. The Minnesota Department of Transportation said the overhead lights on the Highway 43 bridges will be off until mayflies fully hatch, "to reduce the number of mayflies on the bridge." Having mayflies on the bridge can "cause dangerous driving conditions because it becomes slippery," MnDOT said. MnDOT While the insects are harmless, their sometimes overwhelming numbers can make them a nuisance. Still, the Minnesota Department of Natural Resources said they are extremely important in the aquatic food web, and are fed upon by other invertebrates, amphibians, reptiles, fish, birds, and mammals. Mayflies spend 99% of their lives as larvae living in the sediment of freshwater systems like the Mississippi River, the DNR said. The hatching phenomenon in the Mississippi River occurs as the burrowing mayflies emerge all at once to mate, lay eggs and then die. In 2021, a massive hatch in downtown St. Paul blanketed the city's roads and sidewalks. A year later, a hatch near La Crosse, Wisconsin, was so large it showed up on radar.
WebMD
an hour ago
- WebMD
Pill Fatigue
When you live with a chronic condition like HIV, meds are usually a daily occurrence. Something that has to be done to prevent further illness and maintain a positive health status. But it's monotonous. Pill fatigue is real. My pill fatigue is more subconscious, which I'll get into later. I consider daily meds like any other daily routine, like brushing my teeth. Sometimes it's a grind, but it has to be done to maintain good health and a good quality of life. Taking my HIV meds was something I did religiously because it's literally lifesaving. It was no big deal to me. Taking a pill for HIV, diabetes, high blood pressure, or just daily vitamins was all the same to me. But for many, pill fatigue is more serious, to the point they may leave their treatment and take 'pill holidays.' That's where you take a break from taking pills, but it has risks. When you leave HIV treatment, you don't get sick or die immediately. It could take years for the virus to spread and ravage your immune system enough to give opportunistic infections a suitable environment to breed and do damage. Even years away from treatment may not seem abnormal at all. You may feel fine, look fine, and act fine. But your bloodstream is not fine. Your blood is actively at war to save you and losing. As HIV destroys white blood cells that protect you from infection, it becomes more free to breed, and spread throughout your body. It also becomes highly transmissible. Did you catch that last part? And did you catch the implication that meds make the virus untransmittable? Because U=U is a campaign that the advocacy community has been trying to teach people for the last decade. But some have hardened themselves toward HIV and those who live with it, because HIV stigma hasn't changed. Some people still feel fear at the mere mention of HIV. They refuse to accept that HIV is not only treatable, it's completely harmless and untransmittable with effective treatment. But alas, treatment is only effective when taken. As I said, I've had no problem taking meds. But lately, I find myself forgetting to take them. I usually catch it before the day is over, but some of my meds need consistency to be most effective, taken at the same time every day. It could be a serious issue if I continue to forget. I risk my medication losing effectiveness, and that runs the risk of losing access to an entire class of medications. I used to be religious about taking my meds. But over the years, my zeal has diminished. This is what I referred to earlier when I mentioned subconscious pill fatigue (a term I made up). Is that what I'm experiencing? Subconscious pill fatigue? I've taken pills every day for the past 25 years. I didn't think it bothered me, yet I'm forgetting more doses than ever. Am I subconsciously allowing myself to forget? My memory and mental state are certainly factors. Many people who live with HIV develop forgetfulness associated with a neurocognitive decline syndrome, which can happen with HIV. I don't know if I'm experiencing this or just normal aging. But I need to find out. I'm currently working with my doctor to get answers. But forgetting your pills isn't exactly pill fatigue.
The Verge
an hour ago
- The Verge
The Oura Ring 4 just got its first discount for Prime Day
Smartwatches aren't for everyone. Maybe you don't want to wear a screen-equipped gadget to bed, or you're just after something that's less obtrusive. Subtlety is where smart rings like the Oura Ring 4 shine, and Prime Day has knocked down its cost. It costs $296.65 ($52.35) from Amazon, which is both its best price and first significant discount. The fourth-generation Oura Ring brings a handful of meaningful software upgrades over its predecessor, and it's one of the best smart rings out there. It features an accurate algorithm for tracking heart rate and blood oxygen levels, along with improved automatic activity detection. There's no subscription required to use its basic functions, but a $5.99/month subscription is required to access advanced insights and AI-powered features. The Oura Ring 4 is slimmer and more accurate than its predecessor, while adding new AI-powered tools and longer battery life. Read our review. Elsewhere, the changes are subtle but notable. The ring is now slightly slimmer and rounder, available in a wider range of sizes (from 4 to 15), and made entirely from durable titanium. Battery life has also improved significantly, lasting up to seven or eight days on a single charge, compared to three to four days in previous models. Most importantly, the Oura Ring 4 continues to excel as a sleep and recovery tracker. It also tracks light workouts, stress levels, prediction, menstrual cycles, and other essential health metrics, all while remaining discreet on your finger. Of course, as a smart ring, it doesn't offer some of the advanced fitness tracking features smartwatches do, and you'll have to do without perks like push notifications and smart alarms. But if you're a casual athlete who wants a stylish, screen-free tracker that blends seamlessly into your daily life, the Oura Ring 4 is the best smart ring available — especially while it's on sale. Sign up for Verge Deals to get deals on products we've tested sent to your inbox weekly.
